メリーランド州における膀胱癌の臨床試験
メリーランド州内の拠点で、膀胱癌に関する36件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
Evaluation for NCI Surgery Branch Clinical Research Protocols
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
18歳以上 · 全性別 · 2026/10/02更新 · NCT00001823En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
18歳〜120歳 · 全性別 · 2026/10/02更新 · NCT04235764Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- FMH James M Stockman Cancer Institute, Frederick
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- 他10件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
2歳以上 · 全性別 · 2026/09/30更新 · NCT00026884Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- National Institutes of Health Clinical Center, Bethesda
- FMH James M Stockman Cancer Institute, Frederick
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382DK222 Study at Hopkins
- Johns Hopkins Hospital, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07140315Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Oncology Research Pharmacy and lnvestigational Drug Service, Baltimore
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
- Johns Hopkins Hospital, Baltimore
- 他2件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07421700A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Johns Hopkins University ( Site 0843), Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07419295A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Johns Hopkins Hospital, Baltimore
- James M Stockman Cancer Institute, Frederick
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Anne Arundel Urology, Annapolis
- Chesapeake Urology Research Associates, Hanover
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06567743The Vanguard Study: Testing a New Way to Screen for Cancer
- Walter Reed National Military Medical Center, Bethesda
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
18歳〜120歳 · 全性別 · 2026/08/28更新 · NCT02379429FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Johns Hopkins Kimmel Cancer Center, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739Measuring Surgical Recovery After Radical Cystectomy
- John Hopkins Medical Institutions, Baltimore
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT03193970A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/10更新 · NCT04923178LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- John Hopkins Hospital, Baltimore
- Chesapeake Urology Research Associates, Hanover
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Johns Hopkins Hospital, Baltimore
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/07/29更新 · NCT07106762A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- The John Hopkins Hospital, Baltimore
- Maryland Oncology Hematology- Columbia, Rockville
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Chesapeake Urology Research Associates, Hanover
被験者募集中
18歳〜88歳 · 全性別 · 2026/07/02更新 · NCT06394869Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Frederick Health Hospital, Frederick
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/29更新 · NCT07327489Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/25更新 · NCT0531267118F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相
18歳〜120歳 · 全性別 · 2026/05/19更新 · NCT06503146Bladder EpiCheck Product Development Study
- Chesapeake Urology Research Associates, Towson
被験者募集中観察研究
22歳以上 · 全性別 · 2026/04/07更新 · NCT07514143A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863Renal Retention in High Grade Upper Tract Urothelial Cancer
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/01/08更新 · NCT05656235Image-Guided Gynecologic Brachytherapy
- The SKCCC at Johns Hopkins, Baltimore
被験者募集中
18歳〜100歳 · 女性 · 2025/12/18更新 · NCT02993900Blue Light Cystoscopy With Cysview® Registry
- Johns Hopkins Medicine, Baltimore
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT02660645Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Hospital, Baltimore
被験者募集中
18歳以上 · 全性別 · 2025/11/20更新 · NCT07225205Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
- Johns Hopkins University School of Medicine, Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2025/11/18更新 · NCT06525571Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
- Johns Hopkins Hospital, Baltimore
被験者募集中
18歳以上 · 男性 · 2025/11/18更新 · NCT05792722SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- 他1件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Gender Related Coping and Survivorship for Genitourinary Cancers
- Johns Hopkins Hospital, Baltimore
被験者募集中観察研究
18歳以上 · 女性 · 2025/10/03更新 · NCT05649306ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。